Access cutting-edge kidney transplant treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access kidney transplant specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney transplant treatment provided free
The primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom from dialysis in adult participants who are at high risk of DGF after undergoing transplant of deceased donor kidney.
Sponsor: Alexion Pharmaceuticals, Inc.
Check if you qualify for this kidney transplant clinical trial in Stanford, CA
If you're searching for kidney transplant treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.